Voyager Acquisition
Price & Volume
Stats
See more52W Range | $8.40-$27.36 |
Market Cap | $541.2M |
Shares Short | 1,387 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0.21 |
News
See moreYahoo Finance • last month
VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement
Yahoo Finance • 8 months ago
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger–PBBK, VACH, LCTC, and SMLR
Yahoo Finance • 9 months ago
VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology
Yahoo Finance • 11 months ago
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Voyager Acquisition Corp. (NASDAQ: VACH)
About
CEO | Mr. Adeel Rouf Ennis |
Address | 131 Concord Street, Brooklyn, NY, United States, 11201 |
Sector | Financial Services |
Industry | Shell Companies |
Full-Time Employees | 0 |